29: Mycrodose Therapeutics Round 2: Kavalactones, Joint Venture with Thorne, Series A and more‪!‬ Brom Podcast

Mycrodose's CEO Chad Conner and CSO Frank Kochinke return to the podcast to tell us about:   


Mycrodose's partnership with Thorne  
How kavalactones could be used for smoking cessation and weight loss  
Mycrodoses DEA license to cultivate psilocybin mushrooms  
And more!  



⭐️  Follow Mycrodose:  https://mycrodosethera.com/ 

🔥. Follow Brom:  https://www.twitter.com/therealbrom 



⏰  Timestamps:  


1:30 mycrodose lab in San Diego  
6:00 mycrodoses’s DEA license that allows them to cultivate mushrooms  
10:30 natural vs synthetic psilocybin  
13:30 Mycrodose’s joint venture with Thorne 
16:30 Frank’s background  
20:00 - Mycrodose’s Series A  
24:00 Mycrodose’s Business Model  
26:00 What does the future of Mycrodose Therapeutics look like?  
31:00 from Mycro to Macro  
39:30 Distribution agreement with Havn Life